ZAG Regulates the Skin Barrier and Immunity in Atopic Dermatitis
- 1 August 2019
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 139 (8) , 1648-1657.e7
Abstract
No abstract availableKeywords
Funding Information
- Korean Health Technology R & D Project
- Ministry of Health, Welfare and Family Affairs
- Republic of Korea (HI13C0010)
This publication has 43 references indexed in Scilit:
- Evaluation of Adipokines: Apelin, Visfatin, and Resistin in Children with Atopic DermatitisMediators of Inflammation, 2013
- Prognostic role of serum AZGP1, PEDF and PRDX2 in colorectal cancer patientsCarcinogenesis, 2013
- Atopic dermatitis causes lipid accumulation in the liver of NC/Nga mouseJournal of Clinical Biochemistry and Nutrition, 2012
- Atopic dermatitis: a disease of altered skin barrier and immune dysregulationImmunological Reviews, 2011
- Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalitiesJournal of Allergy and Clinical Immunology, 2011
- Zinc α2-Glycoprotein: A Multidisciplinary ProteinMolecular Cancer Research, 2008
- Cytokine modulation of atopic dermatitis filaggrin skin expressionJournal of Allergy and Clinical Immunology, 2007
- Adipocytokines: mediators linking adipose tissue, inflammation and immunityNature Reviews Immunology, 2006
- Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitisNature Genetics, 2006
- Zinc‐α2‐glycoprotein, a lipid mobilizing factor, is expressed and secreted by human (SGBS) adipocytesFEBS Letters, 2004